BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 20476787)

  • 21. Syntheses and biological evaluations of carbosilane dendrimers uniformly functionalized with sialyl alpha(2-->3) lactose moieties as inhibitors for human influenza viruses.
    Oka H; Onaga T; Koyama T; Guo CT; Suzuki Y; Esumi Y; Hatano K; Terunuma D; Matsuoka K
    Bioorg Med Chem; 2009 Aug; 17(15):5465-75. PubMed ID: 19589684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro anti-influenza virus and anti-inflammatory activities of theaflavin derivatives.
    Zu M; Yang F; Zhou W; Liu A; Du G; Zheng L
    Antiviral Res; 2012 Jun; 94(3):217-24. PubMed ID: 22521753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Structure and function of the hemagglutinin of influenza viruses].
    Nobusawa E
    Nihon Rinsho; 1997 Oct; 55(10):2562-9. PubMed ID: 9360372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusion.
    Basu A; Antanasijevic A; Wang M; Li B; Mills DM; Ames JA; Nash PJ; Williams JD; Peet NP; Moir DT; Prichard MN; Keith KA; Barnard DL; Caffrey M; Rong L; Bowlin TL
    J Virol; 2014 Feb; 88(3):1447-60. PubMed ID: 24198411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Oleanolic Acid Derivative Inhibits Hemagglutinin-Mediated Entry of Influenza A Virus.
    Ye M; Liao Y; Wu L; Qi W; Choudhry N; Liu Y; Chen W; Song G; Chen J
    Viruses; 2020 Feb; 12(2):. PubMed ID: 32085430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel trivalent anti-influenza reagent.
    Feng F; Miura N; Isoda N; Sakoda Y; Okamatsu M; Kida H; Nishimura S
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3772-6. PubMed ID: 20488701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations in receptor-binding properties of swine influenza viruses of the H1 subtype after isolation in embryonated chicken eggs.
    Takemae N; Ruttanapumma R; Parchariyanon S; Yoneyama S; Hayashi T; Hiramatsu H; Sriwilaijaroen N; Uchida Y; Kondo S; Yagi H; Kato K; Suzuki Y; Saito T
    J Gen Virol; 2010 Apr; 91(Pt 4):938-48. PubMed ID: 20007353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An influenza A hemagglutinin small-molecule fusion inhibitor identified by a new high-throughput fluorescence polarization screen.
    Yao Y; Kadam RU; Lee CD; Woehl JL; Wu NC; Zhu X; Kitamura S; Wilson IA; Wolan DW
    Proc Natl Acad Sci U S A; 2020 Aug; 117(31):18431-18438. PubMed ID: 32690700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities.
    Stevens J; Blixt O; Glaser L; Taubenberger JK; Palese P; Paulson JC; Wilson IA
    J Mol Biol; 2006 Feb; 355(5):1143-55. PubMed ID: 16343533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The structure and receptor binding properties of the 1918 influenza hemagglutinin.
    Gamblin SJ; Haire LF; Russell RJ; Stevens DJ; Xiao B; Ha Y; Vasisht N; Steinhauer DA; Daniels RS; Elliot A; Wiley DC; Skehel JJ
    Science; 2004 Mar; 303(5665):1838-42. PubMed ID: 14764886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Free energy simulations reveal a double mutant avian H5N1 virus hemagglutinin with altered receptor binding specificity.
    Das P; Li J; Royyuru AK; Zhou R
    J Comput Chem; 2009 Aug; 30(11):1654-63. PubMed ID: 19399777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis and biological evaluation of novel L-ascorbic acid-conjugated pentacyclic triterpene derivatives as potential influenza virus entry inhibitors.
    Wang H; Xu R; Shi Y; Si L; Jiao P; Fan Z; Han X; Wu X; Zhou X; Yu F; Zhang Y; Zhang L; Zhang L; Zhou D; Xiao S
    Eur J Med Chem; 2016 Mar; 110():376-88. PubMed ID: 26866456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants.
    Ilyushina NA; Bovin NV; Webster RG; Govorkova EA
    Antiviral Res; 2006 Jul; 70(3):121-31. PubMed ID: 16516984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probing of the receptor-binding sites of the H1 and H3 influenza A and influenza B virus hemagglutinins by synthetic and natural sialosides.
    Matrosovich MN; Gambaryan AS; Tuzikov AB; Byramova NE; Mochalova LV; Golbraikh AA; Shenderovich MD; Finne J; Bovin NV
    Virology; 1993 Sep; 196(1):111-21. PubMed ID: 8356788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide.
    Deyde VM; Xu X; Bright RA; Shaw M; Smith CB; Zhang Y; Shu Y; Gubareva LV; Cox NJ; Klimov AI
    J Infect Dis; 2007 Jul; 196(2):249-57. PubMed ID: 17570112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A single amino acid substitution in the hemagglutinin of H3N2 subtype influenza A viruses is associated with resistance to the long pentraxin PTX3 and enhanced virulence in mice.
    Job ER; Bottazzi B; Short KR; Deng YM; Mantovani A; Brooks AG; Reading PC
    J Immunol; 2014 Jan; 192(1):271-81. PubMed ID: 24307735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structurally conserved binding sites of hemagglutinin as targets for influenza drug and vaccine development.
    Yusuf M; Konc J; Sy Bing C; Trykowska Konc J; Ahmad Khairudin NB; Janezic D; Wahab HA
    J Chem Inf Model; 2013 Sep; 53(9):2423-36. PubMed ID: 23980878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amantadine-resistant influenza A viruses isolated in South Korea from 2003 to 2009.
    Choi WY; Kim S; Lee N; Kwon M; Yang I; Kim MJ; Cheong SG; Kwon D; Lee JY; Oh HB; Kang C
    Antiviral Res; 2009 Nov; 84(2):199-202. PubMed ID: 19720085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Universal influenza B vaccine based on the maturational cleavage site of the hemagglutinin precursor.
    Bianchi E; Liang X; Ingallinella P; Finotto M; Chastain MA; Fan J; Fu TM; Song HC; Horton MS; Freed DC; Manger W; Wen E; Shi L; Ionescu R; Price C; Wenger M; Emini EA; Cortese R; Ciliberto G; Shiver JW; Pessi A
    J Virol; 2005 Jun; 79(12):7380-8. PubMed ID: 15919893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single residue deletions along the length of the influenza HA fusion peptide lead to inhibition of membrane fusion function.
    Langley WA; Thoennes S; Bradley KC; Galloway SE; Talekar GR; Cummings SF; Varecková E; Russell RJ; Steinhauer DA
    Virology; 2009 Nov; 394(2):321-30. PubMed ID: 19755201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.